Israel Makov Appointed Chairman of Sun Pharma Board

MUMBAI, May 29, 2012 /PRNewswire/ --

The Board of Directors of Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) met today and announced appointment of Mr Israel Makov as Chairman of the Board.

Mr. Makov is the former President and CEO of Teva Pharmaceutical Industries Ltd (2002-2007). He is among Israel's most respected corporate leaders, and is widely credited with Teva's emergence as a global company and a world leader in generic pharmaceuticals.

Speaking on the induction, Mr Dilip Shanghvi, Managing Director of Sun Pharma said "I welcome Mr Makov on behalf of the entire Board and the larger Sun Pharma team.  He is an exceptional leader with deep knowledge and experience in globalizing businesses successfully.  As Sun Pharma continues to rapidly expand its presence worldwide, I am sure that we will benefit immensely from his experience."

On his appointment, Mr Makov said, "I am happy to accept the position of Chairman of the Board.  Sun Pharma is an exciting company poised for substantial global expansion and I look forward to working together with Dilip and his team in realizing their visionary goals."

Profile of Mr Israel Makov

Mr Makov is the former President and CEO of Teva Pharmaceutical Industries Ltd.  He joined Teva in 1995 and led the company's global expansion, managing over 12 acquisitions - two of which were the largest M&A deals in the Israeli history at the time.  Under Mr Makov's leadership, Teva became the undisputed global leader in generic pharmaceutical industry and a global leader in the treatment of Multiple sclerosis.  Prior to joining Teva in 1995, Mr. Makov led a number of companies in various industries, and founded Israel's first biotech company, Interpharm which went public in the US as the first Israeli company in R&D stage.

Currently, Mr Israel Makov is Chairman of Given Imaging - the pioneer developer and world's leading provider of capsule endoscopy, Chairman of BIOLIGHT - a life sciences investment company, Chairman of Micromedic Technologies Ltd. - a cluster of companies engaged in cancer diagnostics, and Chairman of Eltav - the pioneer and world leader in wireless monitoring of industrial valves.  Until recently, Mr Makov was Chairman of Netafim - the global leader in smart irrigation solutions.  Among his other notable engagements: Mr. Makov is a member of the Board of Directors of the Israel National Nanotechnology Initiative; a member of the Executive Board & Management Committee of the Weizmann Institute of Science and on the Board of Governors of the Technion - Israel Institute of Technology.

Mr Israel Makov holds a B.Sc. in Agriculture and M. Sc in Economics from the Hebrew University, Jerusalem.

About Sun Pharmaceutical Industries Ltd.

Established in 1983, listed since 1994 and headquartered in India, Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE:SUNPHARMA, BSE: 524715) is an international, integrated, speciality pharmaceutical company.  It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.  In India, the company is a leader in niche therapy areas of psychiatry, neurology, cardiology, gastroenterology, orthopedics and ophthalmology. The company has strong skills in product development, process chemistry, and manufacturing of complex API, as well as dosage forms. More information about the company can be found at http://www.sunpharma.com.

Contacts

Uday Baldota
Tel +91-22-6645-5645, Xtn 605
Tel Direct +91-22-66455605
Mobile +91-98670-10529
E mail [email protected]

Mira Desai
Tel +91-22-6645-5645, Xtn 606
Tel Direct +91-22-66455606
Mobile +91-98219-23797
E mail [email protected]

SOURCE Sun Pharmaceutical Industries Ltd.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED